Inhibitors of ocular neovascularization: promises and potential problems - PubMed (original) (raw)

Review

. 2005 Mar 23;293(12):1509-13.

doi: 10.1001/jama.293.12.1509.

Affiliations

• PMID: 15784876
• DOI: 10.1001/jama.293.12.1509

Review

Inhibitors of ocular neovascularization: promises and potential problems

Peter van Wijngaarden et al. JAMA. 2005.

No abstract available

PubMed Disclaimer

Similar articles

• Anti-VEGF therapeutic approaches for diabetic macular edema.
  Khurana RN, Do DV, Nguyen QD. Khurana RN, et al. Int Ophthalmol Clin. 2009 Spring;49(2):109-19. doi: 10.1097/IIO.0b013e31819fd8b5. Int Ophthalmol Clin. 2009. PMID: 19349791 No abstract available.
• Anti-VEGF therapy in proliferative diabetic retinopathy.
  Abdallah W, Fawzi AA. Abdallah W, et al. Int Ophthalmol Clin. 2009 Spring;49(2):95-107. doi: 10.1097/IIO.0b013e31819fd84a. Int Ophthalmol Clin. 2009. PMID: 19349790 Review. No abstract available.
• Debate on the various anti-vascular endothelial growth factor drugs.
  Khalili MR, Hosseini H. Khalili MR, et al. Indian J Ophthalmol. 2008 May-Jun;56(3):255-6; author reply 256. doi: 10.4103/0301-4738.40375. Indian J Ophthalmol. 2008. PMID: 18417837 Free PMC article. No abstract available.
• [Treatment of neovascular age-related macular degeneration with bevacizumab].
  Monzón Moreno A. Monzón Moreno A. Farm Hosp. 2006 Nov-Dec;30(6):387-8. doi: 10.1016/s1130-6343(06)74013-2. Farm Hosp. 2006. PMID: 17298199 Spanish. No abstract available.
• Review of anti-VEGF therapy in proliferative diabetic retinopathy.
  Jardeleza MS, Miller JW. Jardeleza MS, et al. Semin Ophthalmol. 2009 Mar-Apr;24(2):87-92. doi: 10.1080/08820530902800330. Semin Ophthalmol. 2009. PMID: 19373692 Review.

Cited by

• Molecular responses of choroidal endothelial cells to elastin derived peptides through the elastin-binding protein (GLB1).
  Skeie JM, Hernandez J, Hinek A, Mullins RF. Skeie JM, et al. Matrix Biol. 2012 Mar;31(2):113-9. doi: 10.1016/j.matbio.2011.11.003. Epub 2011 Dec 2. Matrix Biol. 2012. PMID: 22178079 Free PMC article.
• Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization.
  Izumi-Nagai K, Nagai N, Ozawa Y, Mihara M, Ohsugi Y, Kurihara T, Koto T, Satofuka S, Inoue M, Tsubota K, Okano H, Oike Y, Ishida S. Izumi-Nagai K, et al. Am J Pathol. 2007 Jun;170(6):2149-58. doi: 10.2353/ajpath.2007.061018. Am J Pathol. 2007. PMID: 17525280 Free PMC article.
• Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES).
  Wu L, Martínez-Castellanos MA, Quiroz-Mercado H, Arevalo JF, Berrocal MH, Farah ME, Maia M, Roca JA, Rodriguez FJ; Pan American Collaborative Retina Group (PACORES). Wu L, et al. Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):81-7. doi: 10.1007/s00417-007-0660-z. Epub 2007 Aug 3. Graefes Arch Clin Exp Ophthalmol. 2008. PMID: 17674014
• gamma-Secretase: a multifaceted regulator of angiogenesis.
  Boulton ME, Cai J, Grant MB. Boulton ME, et al. J Cell Mol Med. 2008 Jun;12(3):781-95. doi: 10.1111/j.1582-4934.2008.00274.x. Epub 2008 Feb 8. J Cell Mol Med. 2008. PMID: 18266961 Free PMC article. Review.
• Endoglin promotes angiogenesis in cell- and animal-based models of retinal neovascularization.
  Barnett JM, Suarez S, McCollum GW, Penn JS. Barnett JM, et al. Invest Ophthalmol Vis Sci. 2014 Aug 26;55(10):6490-8. doi: 10.1167/iovs.14-14945. Invest Ophthalmol Vis Sci. 2014. PMID: 25159209 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information